Clinical trial NCT05723328: Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma
Official title: The Effect of a Group Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma in Adult Psychiatric Inpatients in Acute Care
Study type: INTERVENTIONAL
Overall status: TERMINATED
Phase: NA
Conditions: Mental Health Issues
Bipolar Disorder
Depressive
Schizophrenia Spectrum and Other Psychotic Disorders
Anxiety Disorder
Keywords: Internalized stigma
Music therapy
Music Therapy Advocacy Recording Intervention
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Health Issues
Lead sponsor: Hackensack Meridian Health
Sponsor class: OTHER
Collaborators: name: American Music Therapy Association
First posted: 2023-02-10
Enrollment: 7
Sex: ALL
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Pseudo cluster randomized controlled design (Borm et al., 2005) will take advantage of the unit's two separate residential areas
Primary purpose: SUPPORTIVE_CARE

Brief summary: This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.

Detailed description: The primary objective of this study is to determine the effect of a systematic music therapy intervention on internalized stigma of mental illness. The secondary objective is to evaluate the potential for the treatment effect to vary across subject diagnostic categories. This study will also examine the ability of the treatment effect to persist after 3 weeks as an exploratory objective.

Data collection will be conducted in the Acute Care Unit (ACU) of Hackensack Meridian Health Carrier Clinic (HMHCC) over a period of ten months. Subjects will be drawn from the pool of patients admitted to the HMHCC ACU during that time. Adults aged 18-65 with severe mental illness with a diagnosis of bipolar or a related disorder, depressive or anxiety disorder, or schizophrenia spectrum or other psychotic disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5 : 5th ed.; American Psychiatric Association, 2013), of prolonged duration with a significant degree of disability or social dysfunction (Ruggeri et al., 2000) are eligible to participate. Eligible participants must be able to provide informed consent as determined by the doctor.

Eligibility criteria: Inclusion Criteria:

* Admitted to the HMHCC ACU
* Able to read and comprehend the ISMI questionnaire, provide informed consent,
* With a severe mental illness of prolonged duration with a significant degree of disability or social dysfunction

Exclusion Criteria:

* Patients on S1 status (1:1 patient observation) or isolation protocol
* Evidence of organic brain disease, severe acute symptomatology, hearing deficit, and intellectual disability.

Primary outcomes:
measure: Change in the Internalized Stigma of Mental Illness Inventory (ISMI) Score Between Pre and Post MTAR
timeFrame: Post MTAR intervention (day 8-10)
Secondary outcomes:
measure: Change in the ISMI Score Based on Diagnostic Category
timeFrame: Post MTAR intervention (day 8-10)
Other outcomes:
Locations:
city: Belle Mead
country: United States
facility: Carrier Clinic
state: New Jersey
Study officials:
affiliation: Hackensack Meridian Health
name: Zachary D Fischer, PhD, MT-BC
role: PRINCIPAL_INVESTIGATOR
References: